Svoronos Dawn 4
4 · Xenon Pharmaceuticals Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-02+18,475→ 18,475 totalExercise: $38.96Exp: 2033-06-01→ Common Shares (18,475 underlying)
Footnotes (1)
- [F1]Vesting 100% on the earlier of (i) June 1, 2024 or (ii) the day immediately preceding the day of the following year's annual meeting.